DOI QR코드

DOI QR Code

Application of LATE-PCR to Detect Candida and Aspergillus Fungal Pathogens by a DNA Hybridization Assay

  • Gopal, Dhayaalini Bala (School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences, UKM) ;
  • Lim, Chua Ang (Medical Laboratory Sciences Cluster, Faculty of Medicine, UiTM, Kampus Sungai Buloh Jalan Hospital) ;
  • Khaithir, Tzar Mohd Nizam (Department of Medical Microbiology and Immunology, UKMMC) ;
  • Santhanam, Jacinta (School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences, UKM)
  • Received : 2017.12.01
  • Accepted : 2017.12.12
  • Published : 2017.12.28

Abstract

Asymmetric PCR preferentially amplifies one DNA strand for use in DNA hybridization studies. Linear-After-The-Exponential-PCR (LATE-PCR) is an advanced asymmetric PCR method which uses innovatively designed primers at different concentrations. This study aimed to optimise LATE-PCR parameters to produce single-stranded DNA of Candida spp. and Aspergillus spp. for detection via probe hybridisation. The internal transcribed spacer (ITS) region was used to design limiting primer and excess primer for LATE-PCR. Primer annealing and melting temperature, difference of melting temperature between limiting and excess primer and concentration of primers were optimized. In order to confirm the presence of single-stranded DNA, the LATE-PCR product was hybridised with digoxigenin labeled complementary oligonucleotide probe specific for each fungal genus and detected using anti-digoxigenin antibody by dot blotting. Important parameters that determine the production of single-stranded DNA in a LATE-PCR reaction are difference of melting temperature between the limiting and excess primer of at least $5^{\circ}C$ and primer concentration ratio of excess primer to limiting primer at 20:1. LATE-PCR products of Candida albicans, Candida parapsilosis, Candida tropicalis and Aspergillus terreus at up to 1:100 dilution and after 1 h hybridization time, successfully hybridised to respective oligonucleotide probes with no cross reactivity observed between each fungal genus probe and non-target products. For Aspergillus fumigatus, LATE-PCR products were detected at 1:10 dilution and after overnight hybridisation. These results indicate high detection sensitivity for single-stranded DNA produced by LATE-PCR. In conclusion, this advancement of PCR may be utilised to detect fungal pathogens which can aid the diagnosis of invasive fungal disease.

Keywords

References

  1. Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. 2014. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin. Microbiol. Rev. 27: 490-526. https://doi.org/10.1128/CMR.00091-13
  2. Badiee P, Hashemizadeh Z. 2014. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J. Med. Res. 139: 195-204.
  3. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34: 7-14. https://doi.org/10.1086/323335
  4. Pauw BD, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin. Infect. Dis. 46: 1813-1821. https://doi.org/10.1086/588660
  5. Ruping MJ, Vehreschild JJ, Cornely OA. 2008. Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68: 1941-1962. https://doi.org/10.2165/00003495-200868140-00002
  6. Chotirmall SH, Al-Alawi M, Mirkovic B, Lavelle G, Logan PM, Greene CM, et al. 2013. Aspergillus-associated airway disease, inflammation, and the innate immune response. BioMed. Res. Int. 2013: 723129.
  7. Kosmidis C, Denning DW. 2015. The clinical spectrum of pulmonary aspergillosis. Thorax 70: 270-277. https://doi.org/10.1136/thoraxjnl-2014-206291
  8. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001- 2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50: 1091-1100. https://doi.org/10.1086/651263
  9. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-associated infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50: 1101-1111. https://doi.org/10.1086/651262
  10. Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, et al. 2010. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 95: 644-650. https://doi.org/10.3324/haematol.2009.012054
  11. Toma A, Fenaux P, Dreyfus F, Cordonnier C. 2012. Infections in myelodysplastic syndromes. Haematologica 97: 1459-1470. https://doi.org/10.3324/haematol.2012.063420
  12. Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, et al. 2012. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J. Infect. 65: 453-464. https://doi.org/10.1016/j.jinf.2012.08.003
  13. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48: 1695-1703. https://doi.org/10.1086/599039
  14. Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. 2011. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit. Care 15: R198. https://doi.org/10.1186/cc10366
  15. Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, et al. 2013. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med. 39: 2092-2106. https://doi.org/10.1007/s00134-013-3109-3
  16. Muskett H, Shahin J, Eyres G, Harvey S, Rowan K, Harrison D. 2011. Risk factors for invasive fungal disease in critically ill adult patients: a systematic review. Crit. Care 15: R287. https://doi.org/10.1186/cc10574
  17. Xie GH, Fang XM, Fang Q, Wu XM, Jin YH, Wang JL, et al. 2008. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients. Crit. Care 12: R5. https://doi.org/10.1186/cc6766
  18. Low CY, Rotstein C. 2011. Emerging fungal infections in immuno compromised patients. F1000 Med. Rep. 3: 14.
  19. Miyakawa Y, Mabuchi T, Kagaya K, Fukazawal Y. 1992. Isolation and characterization of a species-specific DNA fragment for detection of Candida albicans by polymerase chain reaction. J. Clin. Microbiol. 30: 894-900.
  20. Hopfer RL, Walden P, Setterquist S, Highsmith WE. 1993. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J. Med. Vet. Mycol. 31: 65-75. https://doi.org/10.1080/02681219380000071
  21. Makimura K, Murayama SY, Yamaguchi H. 1994. Detection of a wide range of medically important fungi by the polymerase chain reaction. J. Med. Microbiol. 40: 358-364. https://doi.org/10.1099/00222615-40-5-358
  22. Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A, Mylonakis E. 2012. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin. Infect. Dis. 54: 1322-1331. https://doi.org/10.1093/cid/cis132
  23. Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA, et al. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J. Clin. Microbiol. 35: 1353-1360.
  24. Sibley CD, Peirano G, Church DL. 2012. Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect. Genet. Evol. 12: 505-521. https://doi.org/10.1016/j.meegid.2012.01.011
  25. Citartan M, Tang TH, Tan SC, Hoe CH, Saini R, Tominaga J, et al. 2012. Asymmetric PCR for good quality ssDNA generation towards DNA aptamer production. Songklanakarin J. Sci. Technol. 34: 125-131.
  26. Boysen M, Borja M, del Moral C, Salazar O, Rubio V. 1996. Identification at strain level of Rhizoctoniasolani AG4 isolates by direct sequence of asymmetric PCR products of the ITS regions. Curr. Genet. 29: 174-181. https://doi.org/10.1007/BF02221582
  27. Pierce KE, Sanchez JA, Rice JE, Wangh LJ. 2005. Linear-after-theexponential (LATE)-PCR: primer design criteria for high yields of specific single-stranded DNA and improved real-time detection. Proc. Natl. Acad. Sci. USA 102: 8609-8614. https://doi.org/10.1073/pnas.0501946102
  28. Pierce KE, Wangh LJ. 2011. LATE-PCR and allied technologies: real-time detection strategies for rapid, reliable diagnosis from single cells, pp. 47-66 In Theophilus BDM, Rapley R (eds.), PCR Mutation Detection Protocols. Methods in Molecular Biology (Methods and Protocols), 2nd Ed. Humana Press, New York.
  29. White TJ, Bruns T, Lee S, Taylor J. 1990. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics, pp. 315-322. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds.), PCR protocols: a guide to methods and applications, Academic Press, California.
  30. Henry T, Iwen PC, Hinrichs SH. 2000. Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J. Clin. Microbiol. 38: 1510-1515.
  31. Iwen PC, Hinrichs SH, Rupp ME. 2002. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med. Mycol. 40: 87-109. https://doi.org/10.1080/mmy.40.1.87.109
  32. Korabecna M. 2007. The variability in the fungal ribosomal DNA (ITS1, ITS2, and 5.8S RNA Gene): its biological meaning and application in medical mycology. Communicating Current Research and Educational Topics and Trends in Applied Microbiology 2: 783-787.
  33. Pierce KE, Rice JE, Sanchez JA, Wangh LJ. 2003. Detection of cystic fibrosis alleles from single cells using molecular beacons and a novel method of asymmetric real‐time PCR. Mol. Hum. Reprod. 9: 815-820. https://doi.org/10.1093/molehr/gag100
  34. Sanchez JA, Pierce KE, Rice JE, Wangh LJ. 2004. Linear-After-The- Exponential (LATE)-PCR: an advanced method of asymmetric PCR and its uses in quantitative real-time analysis. Proc. Natl. Acad. Sci. USA 101: 1933-1938. https://doi.org/10.1073/pnas.0305476101
  35. Zhao J, Kong F, Li R, Wang X, Wan Z, Wang D. 2001. Identification of Aspergillus fumigatus and related species by nested PCR targeting ribosomal DNA internal transcribed spacer regions. J. Clin. Microbiol. 39: 2261-2266. https://doi.org/10.1128/JCM.39.6.2261-2266.2001
  36. Hinrikson HP, Hurst SF, De Aguirre L, Morrison CJ. 2005. Molecular methods for the identification of Aspergillus species. Med. Mycol. 43: S129-S137. https://doi.org/10.1080/13693780500064722